Round Table Discussion on Inpatient Use of Continuous Glucose Monitoring at the International Hospital Diabetes Meeting. J Diabetes Sci Technol 2016 Sep;10(5):1174-81
Date
06/12/2016Pubmed ID
27286715Pubmed Central ID
PMC5032965DOI
10.1177/1932296816656380Scopus ID
2-s2.0-85012969799 (requires institutional sign-in at Scopus site) 22 CitationsAbstract
In May 2015 the Diabetes Technology Society convened a panel of 27 experts in hospital medicine and endocrinology to discuss the current and potential future roles of continuous glucose monitoring (CGM) in delivering optimum health care to hospitalized patients in the United States. The panel focused on 3 potential settings for CGM in the hospital, including (1) the intensive care unit (ICU), (2) non-ICU, and (3) continuation of use of home CGM in the hospital. The group reviewed barriers to use and solutions to overcome the barriers. They concluded that CGM has the potential to improve the quality of patient care and can provide useful information to help health care providers learn more about glucose management. Widespread adoption of CGM by hospitals, however, has been limited by added costs and insufficient outcome data.
Author List
Wallia A, Umpierrez GE, Nasraway SA, Klonoff DC, PRIDE InvestigatorsAuthor
Carlos Eduardo Mendez Castrillo MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Blood GlucoseHospitals
Humans
Inpatients
Monitoring, Physiologic